Oruka Therapeutics, Inc. (ORKA)
58.67
-2.00
(-3.30%)
USD |
NASDAQ |
May 21, 16:00
58.67
0.00 (0.00%)
After-Hours: 19:59
Oruka Therapeutics Cash from Investing (Quarterly) : -14.44M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Liminatus Pharma, Inc. | 0.00 |
| MapLight Therapeutics, Inc. | 67.01M |
| Kailera Therapeutics, Inc. | -- |
| Veracyte, Inc. | -127.96M |
| Insight Molecular Diagnostics, Inc. | -0.613M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -23.58M |
| Cash from Financing (Quarterly) | 40.60M |
| Free Cash Flow | -91.19M |
| Free Cash Flow Per Share (Quarterly) | -0.4287 |
| Free Cash Flow to Equity (Quarterly) | -23.53M |
| Free Cash Flow to Firm (Quarterly) | -23.65M |
| Free Cash Flow Yield | -3.18% |